EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Hepcidin as a Molecular Hub of Iron Homeostasis: From BMP–SMAD Signaling to Therapeutic Modulation

Andrea Duminuco iD, Alessandro Costa iD, Federica Pilo, Salvatore Scarso, Cesarina Giallongo, Sebastiano Giallongo, Annalisa Santisi, Arianna Sbriglione, Laura Santocono, Giovanni Caocci, Giuseppe A Palumbo iD

Biomolecules · 25.06.2026 · 16 (7) · 947

DOI: 10.3390/biom16070947 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 25.06.2026. Verfasst von Andrea Duminuco und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical, Surgical Sciences and Advanced Technologies "G.F. Ingrassia", University of Catania, 95123 Catania, Italy. Hauptthemen laut MEDLINE: Hepcidins, Homeostasis, Iron, Bone Morphogenetic Proteins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 139 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepcidin, a 25-amino-acid peptide hormone produced primarily by hepatocytes, is the master regulator of systemic iron homeostasis. By binding the cellular iron exporter ferroportin and inducing its internalization and lysosomal degradation, hepcidin restricts iron entry into plasma from enterocytes, macrophages, and hepatocytes. Its transcription is governed by an intricate molecular network that integrates iron status, erythropoietic demand, oxygen tension, and inflammation, with the BMP–HJV–ALK2/SMAD axis acting as the canonical activating pathway and erythroferrone (ERFE) and matriptase-2 (TMPRSS6) as physiological suppressors. Dysregulation of hepcidin underpins a wide spectrum of human diseases: insufficient hepcidin drives hereditary hemochromatosis and the iron overload of congenital and acquired ineffective erythropoiesis diseases and other ineffective erythropoiesis syndromes, whereas excessive or inappropriate hepcidin contributes to anemia of inflammation, anemia of chronic kidney disease, iron-restricted erythropoiesis in cancer, the iron-restrictive anemia of myelofibrosis, and pathogen-restrictive nutritional immunity. Within the myeloproliferative neoplasm spectrum, the divergent hepcidin patterns observed in polycythemia vera (suppressed) and myelofibrosis (inappropriately elevated through dual BMP/ACVR1/SMAD and IL-6/STAT3 hyperactivation) exemplify the clinical relevance of this axis and underpin two opposite pharmacologic strategies. Over the past decade, hepcidin pathway pharmacology has matured from proof-of-concept to regulatory milestones, shifting perspectives on several diseases and markedly improving clinical approaches.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HepcidinsHomeostasisIronBone Morphogenetic ProteinsSmad ProteinsHumansSignal TransductionAnimals

Stichwörter der Autor:innen

ACVR1/ALK2BMP–SMAD signalingchronic kidney diseasehepcidininflammationiron homeostasismyeloproliferative neoplasmsβ-thalassemia

Substanzen

HepcidinsIronBone Morphogenetic ProteinsSmad Proteins

Autor:innen und Institutionen

  • Department of Medical, Surgical Sciences and Advanced Technologies "G.F. Ingrassia", University of Catania, 95123 Catania, Italy.
  • Hematology Unit with BMT, A.O.U. Policlinico "G.Rodolico-San Marco", 95123 Catania, Italy.
  • Hematology and BMT Unit, "A. Businco" Hospital, ARNAS Brotzu, 09121 Cagliari, Italy.
  • Department of Infectious, Tropical Diseases and Microbiology, IRCCS Sacro Cuore Don Calabria Hospital, Negrar di Valpolicella, 37024 Verona, Italy.
  • Department of Biomedical and Biotechnological Sciences, University of Catania, 95123 Catania, Italy.
  • Department of Medicine and Surgery, University of Enna "Kore", 94100 Enna, Italy.

ORCID-Profile: Andrea Duminuco, Alessandro Costa, Giuseppe A Palumbo

Zitieren

APA

Duminuco, A., Costa, A., Pilo, F., Scarso, S., Giallongo, C., Giallongo, S., Santisi, A., Sbriglione, A., Santocono, L., Caocci, G., & Palumbo, G. A. (2026). Hepcidin as a Molecular Hub of Iron Homeostasis: From BMP–SMAD Signaling to Therapeutic Modulation. Biomolecules, 16(7), 947. https://doi.org/10.3390/biom16070947

Vancouver

Duminuco A, Costa A, Pilo F, Scarso S, Giallongo C, Giallongo S, et al. Hepcidin as a Molecular Hub of Iron Homeostasis: From BMP–SMAD Signaling to Therapeutic Modulation. Biomolecules. 2026;16(7):947. doi:10.3390/biom16070947

BibTeX
@article{Duminuco2026,
  author = {Duminuco, Andrea and Costa, Alessandro and Pilo, Federica and Scarso, Salvatore and Giallongo, Cesarina and Giallongo, Sebastiano and Santisi, Annalisa and Sbriglione, Arianna and Santocono, Laura and Caocci, Giovanni and Palumbo, Giuseppe A},
  title = {Hepcidin as a Molecular Hub of Iron Homeostasis: From BMP–SMAD Signaling to Therapeutic Modulation},
  journal = {Biomolecules},
  year = {2026},
  volume = {16},
  number = {7},
  pages = {947},
  doi = {10.3390/biom16070947}
}
Kostenlos starten →